Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
Clinical trial NCT01915823 · COMPLETED
Trial details
- NCT number
- NCT01915823
- Sponsor
- Meda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2014-02-01
- Enrollment
- 348
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.